In solution-phase peptide trains targeting collagen-like fragments, BOC-L-Hydroxyproline Methyl Ester (C11H19NO5, MW 245.27 g/mol, CAS 74844-91-0) functions as a dual-protected C-terminal proline surrogate. The methyl ester blocks C-terminal ionization during N-terminal BOC removal and subsequent carbodiimide/HBTU couplings, while the 4R hydroxyl remains available for conformational recognition or later modification. A typical batch in a 100 L glass-lined reactor charges 15.0 kg of the methyl ester; BOC deprotection is executed with 4 M HCl in 1,4-dioxane (2.0 mL/mmol, 0–5°C, 2 h), after which the solvent is stripped at 35°C/≤80 mbar. The resulting H-Hyp-OMe hydrochloride is coupled to Boc-Gly-OH or Boc-Pro-OH using HBTU (1.05 equiv) and DIPEA (2.2 equiv) in anhydrous DMF at 0–5°C, with 1.2 volumes of DMF relative to substrate. Coupling completion is checked by HPLC per USP <621> on a 5 μm C18 column (250 × 4.6 mm), with a 10–90% acetonitrile/0.1% TFA gradient over 20 min; residual free amine is held at NMT 0.5 area% at 214 nm. The protected fragment is precipitated from cold MTBE (0–5°C) and dried in a rotary vacuum dryer at 40°C/≤10 mbar until Karl Fischer moisture by USP <921> is NMT 0.2%. If warehouse RH exceeds 60%, pre-drying is applied before charging because the powder is hygroscopic. Residual solvent limits follow ICH Q3C(R9), with DMF NMT 880 ppm, 1,4-dioxane NMT 380 ppm, and MTBE NMT 5000 ppm in the final protected peptide fragment. The output is typically Boc-Gly-Pro-Hyp-OMe or the corresponding Pro-Hyp dipeptide methyl ester, which enters later fragment condensation routes to collagen-mimetic peptides used in fibrillogenesis assays and cell attachment surface coatings.

What Limits Diastereoselectivity in C-4 Fluorination of BOC-Hyp-OMe?

When BOC-L-Hydroxyproline Methyl Ester is converted to 4-fluoroproline derivatives for triple-helix stability studies, the critical processing window is the DAST-mediated fluorination. The substrate is dissolved in anhydrous dichloromethane at 0.1 M under nitrogen and cooled to -78°C in a jacketed glass reactor equipped with an internal PTFE thermowell. Diethylaminosulfur trifluoride (DAST, 1.2 equiv) is added at 0.2 mL/min via syringe pump; the exotherm is controlled to -78°C to -65°C. If the internal temperature exceeds -50°C, the S_N2 pathway competes with elimination to the 3,4-dehydroproline byproduct, and the diastereomeric ratio falls below acceptable downstream limits. After 3 h with gradual warming to 0°C, the reaction is quenched by transfer into cold aqueous NaHCO3, maintaining the quench temperature below 5°C. The crude material is purified on silica gel (200–300 mesh, hexanes/ethyl acetate 4:1 to 2:1), collecting fractions that show a single product spot by TLC under 254 nm. The isolated N-Boc-4-fluoroproline methyl ester is then deprotected with TFA/triisopropylsilane/water (95:2.5:2.5 v/v) at 20–25°C for 1 h, followed by methyl ester hydrolysis in 6 M HCl at 100°C for 12 h to yield the free 4-fluoroproline hydrochloride. Residual dichloromethane in the final free amino acid is controlled by headspace GC per USP <467> at NMT 600 ppm. The terminal 4-fluoroproline isomers are used as conformationally constrained building blocks in collagen peptide programmes; triple-helix melting is recorded by circular dichroism at 222 nm on a thermostatted spectropolarimeter with a heating rate of 0.1°C/min in 50 mM sodium phosphate, pH 7.0. The 4R and 4S diastereomers present opposite triple-helix effects, and stereochemical purity is confirmed by derivatised chiral HPLC on a Daicel Chiralpak AS-H column (250 × 4.6 mm, 1.0 mL/min, hexanes/isopropanol 90:10).

For organocatalyst campaigns based on 4-hydroxyproline-derived prolinol silyl ethers, the methyl ester of BOC-L-Hydroxyproline is reduced to the corresponding alcohol without removing the BOC group. In an anhydrous tetrahydrofuran solution, lithium aluminium hydride (2.2 equiv) is suspended at 0–5°C, and the substrate is added as a 1.0 M THF solution over 45 min. The reduction is held at 0–5°C for 3 h, then quenched by the Fieser method with water (0.1 mL/g of LiAlH4), 15% aqueous NaOH (0.1 mL/g), and water (0.3 mL/g). The aluminium salts are removed by filtration through a 5 μm PTFE filter plate, and the filtrate is dried over anhydrous Na2SO4 and concentrated at 35°C/≤80 mbar. The resulting N-Boc-(2S,4R)-4-hydroxyprolinol is silylated with tert-butyldimethylsilyl chloride (1.0–1.2 equiv) and imidazole (2.0 equiv) in dimethylformamide at 20–25°C for 16 h; the mixture is then quenched with saturated brine and extracted into tert-butyl methyl ether. BOC deprotection with 4 M HCl in 1,4-dioxane at 0–5°C for 2 h gives the hydrochloride salt of the silylated prolinol, which is neutralised prior to use as an enamine organocatalyst for aldol additions and α-functionalisation of ketones. Enantioselective aldol reactions with 5 mol% catalyst at 20°C in cyclohexane are monitored by chiral HPLC using a Chiralpak AD-H column (250 × 4.6 mm, 1.0 mL/min, hexanes/isopropanol 95:5); enantiomeric excess is reported at 220 nm. Residual aluminium in the final neutral catalyst is checked by inductively coupled plasma optical emission spectrometry per USP <233> and held at NMT 100 ppm. The terminal product is a batch-controlled chiral organocatalyst or catalyst precursor used in asymmetric ketone aldol processes; moisture exposure above 60% RH during packaging causes silyl ether hydrolysis and is prevented by argon-filled packaging.

Oxidation to 4-Ketoproline Methyl Ester Derivatives

BOC-L-Hydroxyproline Methyl Ester is oxidised at the C-4 hydroxyl to the corresponding 4-keto derivative when a medicinal chemistry route requires a reversible handle for reductive amination or subsequent heterocycle formation. The oxidation is run as a biphasic dichloromethane/water system at 0–2°C using TEMPO (0.01 equiv), potassium bromide (0.1 equiv), and 10–13% aqueous sodium hypochlorite (1.1 equiv), with the pH maintained at 8.6 ± 0.2 by a pH-stat dosing 5.0 M NaHCO3. The sodium hypochlorite is added through a peristaltic pump at 0.5 mL/min to avoid localised over-oxidation; the internal temperature is held below 2°C. If pH drifts above 9.5 or the temperature exceeds 5°C, elimination to the 3,4-dehydroproline methyl ester becomes the dominant impurity, and the ketone product purity drops below 90 area% as measured by gas chromatography on a 30 m × 0.25 mm DB-5 column after BSTFA derivatisation. After 1.5–2 h, the excess hypochlorite is destroyed with sodium thiosulfate (1.2 equiv relative to NaOCl), the organic phase is separated, washed with water until pH 7.0, dried over MgSO4, and evaporated at 35°C/≤80 mbar. The resulting N-Boc-4-oxo-L-proline methyl ester is purified by silica gel column chromatography with ethyl acetate/hexanes (1:3) to remove TEMPO-related residues. Reductive amination with primary amines using sodium triacetoxyborohydride (1.4 equiv) in 1,2-dichloroethane at 20–25°C then provides N-Boc-4-amino-proline methyl ester intermediates. Residual 1,2-dichloroethane is controlled at NMT 5 ppm in the isolated amino compound according to ICH Q3C(R9) by headspace GC. The terminal 4-aminoproline intermediates are used to access integrin-binding peptidomimetic scaffolds and piperidine-fused candidate libraries, with stereochemical purity confirmed by chiral HPLC at 254 nm.

When a C-Terminal Active Ester Is Required for Fragment Condensation

For downstream API fragment condensations that require a pre-activated hydroxyproline building block, BOC-L-Hydroxyproline Methyl Ester is first saponified to BOC-L-Hydroxyproline and then converted to the N-hydroxysuccinimide or N-hydroxybenzotriazole active ester. The saponification uses lithium hydroxide monohydrate (1.05 equiv) in tetrahydrofuran/water (3:1 v/v) at 0–5°C for 2–4 h. The reaction is stopped by acidification with 10% aqueous citric acid to pH 3.0–3.5, and the product is extracted into ethyl acetate. After brine washing and drying over Na2SO4, the acid is crystallised from ethyl acetate/hexanes (1:3) at -10°C for 4 h. The isolated BOC-L-Hydroxyproline is activated with N,N'-disuccinimidyl carbonate (1.1 equiv) and pyridine (1.1 equiv) in acetonitrile at 20–25°C for 12 h. Concentration at 30°C/≤50 mbar yields the succinimidyl ester as a white crystalline solid, which is stored under argon at -20°C. The active ester is incompatible with primary and secondary amines during storage; accidental amine exposure leads to premature amide bond formation. The active ester is used in stepwise solution coupling to amine-functionalised peptide fragments; acylation is performed with 1.0–1.05 equiv of active ester and 1.2 equiv of N-methylmorpholine in DMF at 0–5°C, followed by aqueous workup. The D-hydroxyproline epimer in the activated intermediate is measured by chiral HPLC after derivatisation and held at NMT 0.1 area%. Water content in the stored active ester is maintained at NMT 0.2% by Karl Fischer to prevent hydrolysis to the parent acid. The terminal succinimidyl or benzotriazole active ester is a direct building block for solution-phase peptide API fragments, particularly where C-terminal epimerisation must be suppressed below 0.1% during coupling to hindered amines.

The C-4 hydroxyl of BOC-L-Hydroxyproline Methyl Ester is converted first to a methanesulfonate leaving group when a clickable 4-azido-L-proline surrogate is required. Mesylation is performed with methanesulfonyl chloride (1.1 equiv) and triethylamine (1.5 equiv) in dichloromethane at 0–5°C for 1 h. If the jacket temperature exceeds 10°C, elimination to the 3,4-dehydroproline methyl ester becomes detectable by GC and the mesylate yield falls below 85 area%. Water is removed by azeotropic distillation with toluene at 40°C/≤80 mbar before displacement. Sodium azide (2.0 equiv) in dimethylformamide is heated at 60°C for 12 h; the mixture is cooled to 20–25°C and quenched into saturated brine. Extraction into ethyl acetate followed by silica gel chromatography with hexanes/ethyl acetate (3:1) yields N-Boc-4-azido-L-proline methyl ester. The azide content is confirmed by FTIR for the 2100 cm⁻¹ asymmetric stretching band, and residual free azide is below detection by ion chromatography with conductivity detection. BOC and methyl ester deprotection are performed sequentially under acidic conditions to give 4-azido-L-proline, which is used as a clickable proline surrogate in copper-catalysed azide-alkyne cycloaddition reactions. The copper catalyst system is typically CuSO4·5H2O (0.1 equiv) and sodium ascorbate (0.2 equiv) in water/tert-butanol (1:1) at 20–25°C for 4 h; resulting triazole conjugates are purified by preparative HPLC at 214 nm. The terminal products are peptide–dye or peptide–polymer conjugates for cellular imaging and hydrogel functionalisation, where the 4-azido-L-proline content is verified by elemental analysis and 1H NMR integration against an internal standard.